Dr. McLaughlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
148 Chestnut St
Needham, MA 02492Phone+1 781-453-5238Fax+1 781-453-5260
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Clinical Cardiac Electrophysiology, 2003 - 2004
- Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 2000 - 2003
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1997 - 2000
- Johns Hopkins University School of MedicineClass of 1997
Certifications & Licensure
- MA State Medical License 1999 - 2026
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Publications & Presentations
PubMed
- 376 citationsImpact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infar...Paul Sorajja, Bernard J. Gersh, David A. Cox, Michael G. McLaughlin, Peter Zimetbaum
European Heart Journal. 2007-07-01 - 153 citationsPrognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab a...Michael G. McLaughlin, Gregg W. Stone, T. Eve Aymong, Graham Gardner, Roxana Mehran
Journal of the American College of Cardiology. 2004-09-15 - 71 citationsImpact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Int...Paul Sorajja, Bernard J. Gersh, David A. Cox, Michael G. McLaughlin, Peter Zimetbaum
Journal of the American College of Cardiology. 2010-04-06
Press Mentions
- Dermavant Announces Presentation of Tapinarof Pivotal Phase 3 PSOARING Data at Fall Clinical Dermatology ConferenceOctober 22nd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: